TCF1 links GIPR signaling to the control of beta cell function and survival

Jonathan E Campbell1, John R Ussher1, Erin E Mulvihill1

  • 1Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada.

Nature Medicine
|December 8, 2015
PubMed

Insights

The glucose-dependent insulinotropic polypeptide receptor (GIPR) is crucial for beta cell function and survival. Targeting the GIPR-TCF1 axis may offer new therapies for type 2 diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Diabetes Research

Background:

  • Glucagon-like peptide-1 receptor (GLP-1R) is a validated diabetes target.
  • The role of glucose-dependent insulinotropic polypeptide receptor (GIPR) in beta cell function is unclear.
  • Beta cell dysfunction and loss are key in type 2 diabetes.

Purpose of the Study:

  • To investigate the specific role of GIPR in beta cells.
  • To explore the molecular mechanisms linking GIPR signaling to beta cell survival.
  • To evaluate the therapeutic potential of the GIPR-TCF1 axis in diabetes.

Main Methods:

  • Generated beta cell-specific GIPR knockout mice (Gipr(-/-βCell)).
  • Assessed insulin secretion, beta cell apoptosis, and TCF1 expression.
  • Utilized in vitro studies with human and mouse islets, including gene knockdown and rescue experiments.
  • Examined Tcf7 knockout mice for glucose tolerance and beta cell injury sensitivity.

Main Results:

  • Beta cell-specific GIPR ablation reduced insulin secretion and increased apoptosis.
  • GIPR signaling promotes beta cell expression of TCF1 via an ERK-dependent pathway.
  • TCF1 levels are decreased in islets from diabetic mice and humans.
  • TCF1 deficiency impairs GIP's protective effects and exacerbates beta cell injury.

Conclusions:

  • The GIPR-TCF1 axis is vital for beta cell function and survival.
  • GIPR signaling, through TCF1, protects beta cells from apoptosis.
  • Targeting the GIPR-TCF1 pathway presents a promising therapeutic strategy for type 2 diabetes.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.9K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.3K